• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.06% Nasdaq Up0.17%

    Regeneron Pharmaceuticals, Inc. (REGN)

    -NasdaqGS
    430.72 Up 6.93(1.64%) 11:09AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Analyst OpinionGet Analyst Opinion for:
    Recommendation Summary*
    Mean Recommendation (this week):2.0
    Mean Recommendation (last week):2.0
    Change:0.0

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Price Target Summary
    Mean Target:404.30
    Median Target:413.00
    High Target:480.00
    Low Target:315.00
    No. of Brokers:20

    Data provided by Thomson/First Call

    Upgrades & Downgrades History
    DateResearch FirmActionFromTo
    Jul 21, 2014ArgusInitiated Buy
    Apr 16, 2014Canaccord GenuityInitiated Buy
    Feb 13, 2014OppenheimerDowngradeOutperformPerform
    Aug 22, 2013OppenheimerInitiated Outperform
    May 17, 2013UBSInitiated Neutral
    Feb 28, 2013BarclaysInitiated Overweight
    Jan 10, 2012Robert W. BairdUpgradeNeutralOutperform
    Apr 29, 2011RBC Capital MktsDowngradeOutperformSector Perform
    Apr 27, 2011Boenning & ScattergoodInitiated Outperform
    Apr 7, 2011MP AdvisorsUpgradeMarket PerformOutperform

    More Upgrades & Downgrades for REGN

    Data provided by Briefing.com - Take a free trial
    Complete Live market analysis of the U.S. stock and bond markets, technology stocks, economic releases, earnings reports, and day trading highlights.

    Recommendation Trends
    Current MonthLast MonthTwo Months AgoThree Months Ago
    Strong Buy0886
    Buy0666
    Hold0777
    Underperform0000
    Sell0000

    Data provided by Thomson/First Call


    Currency in USD.